AR and prostate carcinoma: Thus, it is conceivable that a combination of immune suppressive effects and the oncogenic role of androgen/AR axis could potentially augment the magnitude of SARS-CoV-2 infection in men with prostate cancer, resulting in an unfavorable cancer outcome.